{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:19:37Z","timestamp":1789507177260,"version":"build-2803163510"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"University of Padjadjaran"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The COVID-19 pandemic, caused by SARS-CoV-2, has intensified the search for effective antiviral agents. This study investigates the inhibitory potential of 473 flavonoids from the genus <jats:italic>Erythrina<\/jats:italic> against the key enzyme of SARS-CoV-2, RNA-dependent RNA polymerase (RdRp). Virtual screening campaign using molecular docking identified 128 flavonoids with stronger binding energies to RdRp than remdesivir, a WHO-endorsed drug. Lipinski\u2019s Rule of Five and ADMET profiling suggested butein (<jats:bold>119<\/jats:bold>) as the promising RdRp inhibitor. Moreover, molecular dynamics simulations revealed that <jats:bold>119<\/jats:bold> binds effectively to RdRp and interacts with the RNA template and primer, suggesting a multi-faceted inhibitory mechanism. Our findings highlight the potential of Erythrina-derived flavonoids, particularly compound <jats:bold>119<\/jats:bold>, as potent RdRp inhibitors, warranting further experimental studies.<\/jats:p>","DOI":"10.1038\/s41598-025-97311-w","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T08:45:43Z","timestamp":1745484343000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Exploring Erythrina flavonoids as potential SARS-CoV-2 RdRp inhibitors through virtual screening, in silico ADMET evaluation, and molecular dynamics simulation studies"],"prefix":"10.1038","volume":"15","author":[{"given":"Tati","family":"Herlina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicki","family":"Nishinarizki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abd. Wahid Rizaldi","family":"Akili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ari","family":"Hardianto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabarni","family":"Gaffar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muchtaridi","family":"Muchtaridi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalifah","family":"Latip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,24]]},"reference":[{"key":"97311_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2022.02.003","author":"TJ Gluckman","year":"2022","unstructured":"Gluckman, T. J. et al. 2022 ACC expert consensus decision pathway on cardiovascular sequelae of COVID-19 in adults: Myocarditis and other myocardial involvement, post-acute sequelae of SARS-CoV-2 infection, and return to play: A report of the American College of Cardiology Solution Set Oversight Committee. J. Am. Coll. Cardiol. https:\/\/doi.org\/10.1016\/j.jacc.2022.02.003 (2022).","journal-title":"J. Am. Coll. Cardiol."},{"key":"97311_CR2","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1093\/eurheartj\/ehac031","volume":"43","author":"B Raman","year":"2022","unstructured":"Raman, B., Bluemke, D. A., L\u00fcscher, T. F. & Neubauer, S. Long COVID: Post-acute sequelae of COVID-19 with a cardiovascular focus. Eur. Heart J. 43, 1157\u20131172 (2022).","journal-title":"Eur. Heart J."},{"key":"97311_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1915","author":"Y Zhang","year":"2020","unstructured":"Zhang, Y. et al. Management of heart failure patients with COVID-19: A joint position paper of the Chinese Heart Failure Association & National Heart Failure Committee and the Heart Failure Association of the European Society of Cardiology. Eur. J. Heart Fail. https:\/\/doi.org\/10.1002\/ejhf.1915 (2020).","journal-title":"Eur. J. Heart Fail."},{"key":"97311_CR4","doi-asserted-by":"publisher","DOI":"10.1080\/22221751.2020.1719902","author":"JFW Chan","year":"2020","unstructured":"Chan, J. F. W. et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg. Microbes Infect. https:\/\/doi.org\/10.1080\/22221751.2020.1719902 (2020).","journal-title":"Emerg. Microbes Infect."},{"key":"97311_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2368-8","author":"HS Hillen","year":"2020","unstructured":"Hillen, H. S. et al. Structure of replicating SARS-CoV-2 polymerase. Nature https:\/\/doi.org\/10.1038\/s41586-020-2368-8 (2020).","journal-title":"Nature"},{"key":"97311_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s11030-021-10215-5","author":"I Celik","year":"2022","unstructured":"Celik, I., Erol, M. & Duzgun, Z. In silico evaluation of potential inhibitory activity of remdesivir, favipiravir, ribavirin and galidesivir active forms on SARS-CoV-2 RNA polymerase. Mol. Divers. https:\/\/doi.org\/10.1007\/s11030-021-10215-5 (2022).","journal-title":"Mol. Divers."},{"key":"97311_CR7","doi-asserted-by":"publisher","DOI":"10.1139\/cjpp-2020-0734","author":"MA Unal","year":"2021","unstructured":"Unal, M. A. et al. Ribavirin shows antiviral activity against sars-cov-2 and downregulates the activity of tmprss2 and the expression of ace2 in vitro. Can. J. Physiol. Pharmacol. https:\/\/doi.org\/10.1139\/cjpp-2020-0734 (2021).","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"97311_CR8","doi-asserted-by":"publisher","DOI":"10.1021\/acscentsci.0c01242","author":"F Byl\u00e9hn","year":"2021","unstructured":"Byl\u00e9hn, F. et al. Modeling the binding mechanism of remdesivir, favilavir, and ribavirin to SARS-CoV-2 RNA-dependent RNA polymerase. ACS Cent. Sci. https:\/\/doi.org\/10.1021\/acscentsci.0c01242 (2021).","journal-title":"ACS Cent. Sci."},{"key":"97311_CR9","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.cmi.2022.04.018","volume":"28","author":"TC Lee","year":"2022","unstructured":"Lee, T. C. et al. Remdesivir for the treatment of COVID-19: A systematic review and meta-analysis. Clin. Microbiol. Infect. 28, 1203\u20131210 (2022).","journal-title":"Clin. Microbiol. Infect."},{"key":"97311_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/plants11141886","author":"AM Metwaly","year":"2022","unstructured":"Metwaly, A. M. et al. The computational preventive potential of the rare flavonoid, patuletin, isolated from tagetes patula, against SARS-CoV-2. Plants https:\/\/doi.org\/10.3390\/plants11141886 (2022).","journal-title":"Plants"},{"key":"97311_CR11","doi-asserted-by":"publisher","first-page":"768708","DOI":"10.3389\/fphar.2021.768708","volume":"12","author":"X Xiong","year":"2021","unstructured":"Xiong, X. et al. Insights into amentoflavone: A natural multifunctional biflavonoid. Front. Pharmacol. 12, 768708 (2021).","journal-title":"Front. Pharmacol."},{"key":"97311_CR12","doi-asserted-by":"publisher","DOI":"10.1007\/s11030-022-10459-9","author":"D Dey","year":"2023","unstructured":"Dey, D. et al. Amentoflavone derivatives significantly act towards the main protease (3CLPRO\/MPRO) of SARS-CoV-2: in silico admet profiling, molecular docking, molecular dynamics simulation, network pharmacology. Mol. Divers. https:\/\/doi.org\/10.1007\/s11030-022-10459-9 (2023).","journal-title":"Mol. Divers."},{"key":"97311_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11101-021-09759-z","volume":"21","author":"MM Alzaabi","year":"2022","unstructured":"Alzaabi, M. M. et al. Flavonoids are promising safe therapy against COVID-19. Phytochem. Rev. 21, 1\u201322 (2022).","journal-title":"Phytochem. Rev."},{"key":"97311_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-14664-2","author":"F Munaf\u00f2","year":"2022","unstructured":"Munaf\u00f2, F. et al. Quercetin and luteolin are single-digit micromolar inhibitors of the SARS-CoV-2 RNA-dependent RNA polymerase. Sci. Rep. https:\/\/doi.org\/10.1038\/s41598-022-14664-2 (2022).","journal-title":"Sci. Rep."},{"key":"97311_CR15","doi-asserted-by":"publisher","DOI":"10.7324\/JAPS.2023.130209","author":"V Nishinarizki","year":"2023","unstructured":"Nishinarizki, V. et al. Virtual screening campaigns and ADMET evaluation to unlock the potency of flavonoids from Erythrina as 3CLpro SARS-COV-2 inhibitors. J. Appl. Pharm. Sci. https:\/\/doi.org\/10.7324\/JAPS.2023.130209 (2023).","journal-title":"J. Appl. Pharm. Sci."},{"key":"97311_CR16","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.indcrop.2018.06.028","volume":"123","author":"NM Fahmy","year":"2018","unstructured":"Fahmy, N. M., Al-Sayed, E., El-Shazly, M. & Singab, A. N. Comprehensive review on flavonoids biological activities of Erythrina plant species. Ind. Crops Prod. 123, 500\u2013538. https:\/\/doi.org\/10.1016\/j.indcrop.2018.06.028 (2018).","journal-title":"Ind. Crops Prod."},{"key":"97311_CR17","doi-asserted-by":"publisher","DOI":"10.1055\/s-0028-1088395","author":"JS Lee","year":"2009","unstructured":"Lee, J. S. et al. Prenylisoflavonoids from Erythrina senegalensis as novel HIV-1 protease inhibitors. Planta Med. https:\/\/doi.org\/10.1055\/s-0028-1088395 (2009).","journal-title":"Planta Med."},{"key":"97311_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/cbdv.201900511","author":"NM Fahmy","year":"2020","unstructured":"Fahmy, N. M. et al. Breaking down the barriers to a natural antiviral agent: Antiviral activity and molecular docking of Erythrina speciosa extract, fractions, and the major compound. Chem. Biodivers. https:\/\/doi.org\/10.1002\/cbdv.201900511 (2020).","journal-title":"Chem. Biodivers."},{"key":"97311_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/pro.3934","author":"DS Goodsell","year":"2021","unstructured":"Goodsell, D. S., Sanner, M. F., Olson, A. J. & Forli, S. The AutoDock suite at 30. Protein Sci. https:\/\/doi.org\/10.1002\/pro.3934 (2021).","journal-title":"Protein Sci."},{"key":"97311_CR20","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc1560","author":"W Yin","year":"2020","unstructured":"Yin, W. et al. Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir. Science (1979) https:\/\/doi.org\/10.1126\/science.abc1560 (2020).","journal-title":"Science (1979)"},{"key":"97311_CR21","doi-asserted-by":"publisher","DOI":"10.22146\/IJC.65951","author":"A Hardianto","year":"2021","unstructured":"Hardianto, A. et al. Exploring the potency of nigella sativa seed in inhibiting sars-cov-2 main protease using molecular docking and molecular dynamics simulations. Indonesian J. Chem. https:\/\/doi.org\/10.22146\/IJC.65951 (2021).","journal-title":"Indonesian J. Chem."},{"key":"97311_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/srep42717","author":"A Daina","year":"2017","unstructured":"Daina, A., Michielin, O. & Zoete, V. SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. https:\/\/doi.org\/10.1038\/srep42717 (2017).","journal-title":"Sci. Rep."},{"key":"97311_CR23","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.5b00104","author":"DEV Pires","year":"2015","unstructured":"Pires, D. E. V., Blundell, T. L. & Ascher, D. B. pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J. Med. Chem. https:\/\/doi.org\/10.1021\/acs.jmedchem.5b00104 (2015).","journal-title":"J. Med. Chem."},{"key":"97311_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-017-1955-7","author":"A Hardianto","year":"2017","unstructured":"Hardianto, A., Yusuf, M., Liu, F. & Ranganathan, S. Exploration of charge states of balanol analogues acting as ATP-competitive inhibitors in kinases. BMC Bioinform. https:\/\/doi.org\/10.1186\/s12859-017-1955-7 (2017).","journal-title":"BMC Bioinform."},{"key":"97311_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-018-2373-1","author":"A Hardianto","year":"2019","unstructured":"Hardianto, A., Khanna, V., Liu, F. & Ranganathan, S. Diverse dynamics features of novel protein kinase C (PKC) isozymes determine the selectivity of a fluorinated balanol analogue for PKC\u03f5. BMC Bioinform. https:\/\/doi.org\/10.1186\/s12859-018-2373-1 (2019).","journal-title":"BMC Bioinform."},{"key":"97311_CR26","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.7b00504","author":"A Hardianto","year":"2018","unstructured":"Hardianto, A., Liu, F. & Ranganathan, S. Molecular dynamics pinpoint the global fluorine effect in balanoid binding to PKC\u03f5 and PKA. J. Chem. Inf. Model https:\/\/doi.org\/10.1021\/acs.jcim.7b00504 (2018).","journal-title":"J. Chem. Inf. Model"},{"key":"97311_CR27","unstructured":"Case, D. A. et al. AMBER 2020 (2020)."},{"key":"97311_CR28","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jctc.9b00591","author":"C Tian","year":"2020","unstructured":"Tian, C. et al. Ff19SB: Amino-acid-specific protein backbone parameters trained against quantum mechanics energy surfaces in solution. J. Chem. Theory Comput. https:\/\/doi.org\/10.1021\/acs.jctc.9b00591 (2020).","journal-title":"J. Chem. Theory Comput."},{"key":"97311_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s13346-020-00724-5","author":"RM Haley","year":"2020","unstructured":"Haley, R. M., Gottardi, R., Langer, R. & Mitchell, M. J. Cyclodextrins in drug delivery: Applications in gene and combination therapy. Drug Deliv. Transl. Res. https:\/\/doi.org\/10.1007\/s13346-020-00724-5 (2020).","journal-title":"Drug Deliv. Transl. Res."},{"key":"97311_CR30","doi-asserted-by":"publisher","first-page":"276260","DOI":"10.1155\/2014\/276260","volume":"2014","author":"A Vyas","year":"2014","unstructured":"Vyas, A., Kumar Sonker, A. & Gidwani, B. Carrier-based drug delivery system for treatment of acne. Sci. World J. 2014, 276260 (2014).","journal-title":"Sci. World J."},{"key":"97311_CR31","doi-asserted-by":"publisher","DOI":"10.2174\/0929867043364621","author":"J Blanchfield","year":"2012","unstructured":"Blanchfield, J. & Toth, I. Lipid, sugar and liposaccharide based delivery systems 2. Curr. Med. Chem. https:\/\/doi.org\/10.2174\/0929867043364621 (2012).","journal-title":"Curr. Med. Chem."},{"key":"97311_CR32","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2021.1875886","author":"A Mishra","year":"2022","unstructured":"Mishra, A. & Rathore, A. S. RNA dependent RNA polymerase (RdRp) as a drug target for SARS-CoV2. J. Biomol. Struct. Dyn. https:\/\/doi.org\/10.1080\/07391102.2021.1875886 (2022).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"97311_CR33","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.0c05846","author":"V Mulpuru","year":"2021","unstructured":"Mulpuru, V. & Mishra, N. In silico prediction of fraction unbound in human plasma from chemical fingerprint using automated machine learning. ACS Omega https:\/\/doi.org\/10.1021\/acsomega.0c05846 (2021).","journal-title":"ACS Omega"},{"key":"97311_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06185-6","author":"JI Guerrero","year":"2021","unstructured":"Guerrero, J. I. et al. Central and peripheral nervous system involvement by COVID-19: A systematic review of the pathophysiology, clinical manifestations, neuropathology, neuroimaging, electrophysiology, and cerebrospinal fluid findings. BMC Infect. Dis. https:\/\/doi.org\/10.1186\/s12879-021-06185-6 (2021).","journal-title":"BMC Infect. Dis."},{"key":"97311_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12038-021-00165-3","volume":"46","author":"SS Chaudhury","year":"2021","unstructured":"Chaudhury, S. S. et al. COVID-19 and central nervous system interplay: A big picture beyond clinical manifestation. J. Biosci. 46, 1\u201312 (2021).","journal-title":"J. Biosci."},{"key":"97311_CR36","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1177\/2042098612469335","volume":"4","author":"MP Doogue","year":"2013","unstructured":"Doogue, M. P. & Polasek, T. M. The ABCD of clinical pharmacokinetics. Ther. Adv. Drug Saf. 4, 5\u20137 (2013).","journal-title":"Ther. Adv. Drug Saf."},{"key":"97311_CR37","doi-asserted-by":"publisher","DOI":"10.1021\/mp300023x","author":"S Wang","year":"2012","unstructured":"Wang, S. et al. ADMET evaluation in drug discovery. 12. Development of binary classification models for prediction of hERG potassium channel blockage. Mol. Pharm. https:\/\/doi.org\/10.1021\/mp300023x (2012).","journal-title":"Mol. Pharm."},{"key":"97311_CR38","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.phytol.2014.12.014","volume":"11","author":"RB Semwal","year":"2015","unstructured":"Semwal, R. B., Semwal, D. K., Combrinck, S. & Viljoen, A. Butein: From ancient traditional remedy to modern nutraceutical. Phytochem. Lett. 11, 188\u2013201. https:\/\/doi.org\/10.1016\/j.phytol.2014.12.014 (2015).","journal-title":"Phytochem. Lett."},{"key":"97311_CR39","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.2c02315","author":"S Bhatt","year":"2022","unstructured":"Bhatt, S. et al. Assessment of the CYP1A2 inhibition-mediated drug interaction potential for pinocembrin using in silico, in vitro, and in vivo approaches. ACS Omega https:\/\/doi.org\/10.1021\/acsomega.2c02315 (2022).","journal-title":"ACS Omega"},{"key":"97311_CR40","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3390\/v10020076","volume":"10","author":"S Venkataraman","year":"2018","unstructured":"Venkataraman, S., Prasad, B. V. L. S. & Selvarajan, R. RNA dependent RNA polymerases: Insights from structure, function and evolution. Viruses 10, 76 (2018).","journal-title":"Viruses"},{"key":"97311_CR41","doi-asserted-by":"publisher","first-page":"113201","DOI":"10.1016\/j.ejmech.2021.113201","volume":"213","author":"L Tian","year":"2021","unstructured":"Tian, L. et al. RNA-dependent RNA polymerase (RdRp) inhibitors: The current landscape and repurposing for the COVID-19 pandemic. Eur. J. Med. Chem. 213, 113201 (2021).","journal-title":"Eur. J. Med. Chem."},{"key":"97311_CR42","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M808889200","author":"JQ Hang","year":"2009","unstructured":"Hang, J. Q. et al. Slow binding inhibition and mechanism of resistance of non-nucleoside polymerase inhibitors of Hepatitis C virus. J. Biol. Chem. https:\/\/doi.org\/10.1074\/jbc.M808889200 (2009).","journal-title":"J. Biol. Chem."},{"key":"97311_CR43","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.02628-05","author":"S Le Pogam","year":"2006","unstructured":"Le Pogam, S. et al. Selection and characterization of replicon variants dually resistant to thumb- and palm-binding nonnucleoside polymerase inhibitors of the hepatitis C virus. J. Virol. https:\/\/doi.org\/10.1128\/jvi.02628-05 (2006).","journal-title":"J. Virol."},{"key":"97311_CR44","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M505423200","author":"S Di Marco","year":"2005","unstructured":"Di Marco, S. et al. Interdomain communication in hepatitis C virus polymerase abolished by small molecule inhibitors bound to a novel allosteric site. J. Biol. Chem. https:\/\/doi.org\/10.1074\/jbc.M505423200 (2005).","journal-title":"J. Biol. Chem."},{"key":"97311_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9050893","author":"K Zandi","year":"2021","unstructured":"Zandi, K. et al. Baicalein and baicalin inhibit sars-cov-2 RNA-dependent-RNA polymerase. Microorganisms https:\/\/doi.org\/10.3390\/microorganisms9050893 (2021).","journal-title":"Microorganisms"},{"key":"97311_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.639614","author":"M Srivastava","year":"2021","unstructured":"Srivastava, M., Mittal, L., Kumari, A. & Asthana, S. Molecular dynamics simulations reveal the interaction fingerprint of remdesivir triphosphate pivotal in allosteric regulation of SARS-CoV-2 RdRp. Front. Mol. Biosci. https:\/\/doi.org\/10.3389\/fmolb.2021.639614 (2021).","journal-title":"Front. Mol. Biosci."},{"key":"97311_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0248553","author":"NM Anand","year":"2021","unstructured":"Anand, N. M. et al. A comprehensive SARS-CoV-2 genomic analysis identifies potential targets for drug repurposing. PLoS ONE https:\/\/doi.org\/10.1371\/journal.pone.0248553 (2021).","journal-title":"PLoS ONE"},{"key":"97311_CR48","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/17460441.2018.1403419","volume":"13","author":"X Liu","year":"2018","unstructured":"Liu, X. et al. Molecular dynamics simulations and novel drug discovery. Expert Opin. Drug Discov. 13, 23\u201337 (2018).","journal-title":"Expert Opin. Drug Discov."},{"key":"97311_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2020.08.116","author":"Y Jiang","year":"2021","unstructured":"Jiang, Y., Yin, W. & Xu, H. E. RNA-dependent RNA polymerase: Structure, mechanism, and drug discovery for COVID-19. Biochem. Biophys. Res. Commun. https:\/\/doi.org\/10.1016\/j.bbrc.2020.08.116 (2021).","journal-title":"Biochem. Biophys. Res. Commun."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97311-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97311-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97311-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T08:45:45Z","timestamp":1745484345000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97311-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,24]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["97311"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-97311-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,24]]},"assertion":[{"value":"10 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14259"}}